CAS 2133417-13-5

Ralmitaront

CAS : 2133417-13-5

Ralmitaront

Degré de pureté : ≥98%

Masse moléculaire : 314.38g/mol

Ref: 54-BUP07615

Ralmitaront

CAS : 2133417-13-5

Ralmitaront (RO6889450) is a potent, orally active partial agonist of the trace amine-associated receptor 1 (TAAR1).

Formule : C₁₇H₂₂N₄O₂

Degré de pureté : 99.71% - 99.79%

Couleur et forme : Solid

Masse moléculaire : 314.38

Ref: TM-T9183

Ralmitaront

CAS : 2133417-13-5

Ralmitaront is a Chinese medicinal analog that has shown promising results in the treatment of tumors and cancer. It works by inducing apoptosis, or programmed cell death, in cancer cells. Ralmitaront is a kinase inhibitor that targets specific human kinases involved in cancer cell growth and proliferation. It has been shown to inhibit the activity of several proteins involved in tumor growth, including protein kinase C and tyrosine kinases. Ralmitaront has also been found in urine samples of cancer patients, suggesting that it may have potential as a non-invasive diagnostic tool for cancer detection. Overall, Ralmitaront shows great promise as an anticancer agent and warrants further research into its potential therapeutic applications.

Formule : C₁₇H₂₂N₄O₂

Degré de pureté : Min. 95%

Masse moléculaire : 314.4 g/mol

Ref: 3D-IKD41713